Idenix Pharmaceuticals, Inc. (IDIX) Posts Q2 EPS Loss of $0.15, Revenues Miss Expectations

Go back to Idenix Pharmaceuticals, Inc. (IDIX) Posts Q2 EPS Loss of $0.15, Revenues Miss Expectations